Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microvascular Resistance Reserve Assessment Derived From Absolute Flow and Resistance by PET and CT

NCT06069401 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT06069401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06069401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microvascular Resistance Reserve Assessment Derived From Absolute Flow and Resistance by PET and CT
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2024
Completion date
July 1, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, microvascular coronary artery disease